Researchers find new COPD therapy device makes breathing easier

January 30, 2014 by Jeff Renaud, University of Western Ontario

A new device designed to help people suffering from chronic obstructive pulmonary disease (COPD) and other mucus producing lung diseases developed by Trudell Medical International has been clinically tested by researchers at Western University and results show it improves breathlessness and the ability to move mucus, as well as betters a patient's quality of life.

The Aerobika Oscillating Positive Expiratory Pressure (OPEP) Therapy System is a drug-free, easy to use, hand-held that aims to help people with lung disease breathe easier.

The OPEP device was tested by Dr. David McCormack and Grace Parraga from Western's Schulich School of Medicine & Dentistry and their team at Robarts Research Institute.

Initial study results showed that participants using it were able to more easily move mucus up and out of the lungs, which allowed for improved breathing and quality of life.

"We're really fortunate at Western to have Trudell Medical International, an innovative medical device company focused on lung disease, based in London," says Parraga. "Trudell has been working tirelessly for years on new treatments for lung disease and at the same time, we've been developing, in parallel, new ways to look at lung disease using novel medical imaging methods, developed here at Robarts. It is an outstanding example of university-industry collaboration that we have achieved in London."

Trudell CEO Mitch Baran says that he and his team agree wholeheartedly with Parraga and believes the synergy created by this collaboration was instrumental in launching this device, which has the ability to assist the world's estimated 600-million COPD sufferers and others battling phlegm-producing .

"Drug treatment is often the preferred method, but may not be completely effective in achieving adequate airway clearance," says Baran. "Each patient's COPD, be it chronic bronchitis, emphysema or any other lung disease, is unique and may need a variety of therapies. The innovation built into our Aerobika OPEP device delivers excellent effectiveness while being very easy to use."

Baran says the overall goal of the device is to ensure the patient can maintain their treatments to control their symptoms, breathe easier, enjoy a better quality of life and ultimately, stay out of the hospital.

The research team, including PhD candidate Sarah Svenningsen and MSc candidate Gregory Paulin, evaluated the OPEP device using a novel approach that involves inhaled hyperpolarized Helium-3 (a light, non-radioactive isotope of helium) and MRI images before and after OPEP therapy.

Explore further: Tiny, implantable coil promises hope for emphysema patients

More information: For more information, including videos and scans, please visit: communications.uwo.ca/media/copd/

Related Stories

Tiny, implantable coil promises hope for emphysema patients

May 20, 2013
A small, easily implantable device called the Lung Volume Reduction Coil (LVRC) may play a key role in the treatment of two types of emphysema, according to a study conducted in Europe. Results of the study indicate the beneficial ...

Yoga practice beneficial to patients with COPD

October 28, 2013
An estimated 24 million Americans may have COPD, which includes chronic bronchitis, emphysema, or both. Patients with COPD have trouble pushing used air out of their lungs, making it difficult to take in healthy new air. ...

Anoro ellipta approved for COPD

December 18, 2013
(HealthDay)—A new inhaled drug to treat a serious lung condition called chronic obstructive pulmonary disease (COPD) has been approved by the U.S. Food and Drug Administration.

Medical acoustics, UB reaching COPD patients with new Lung Flute

September 7, 2011
An easy-to-use device developed by a local biomedical company is providing relief to Buffalo-area patients suffering from chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema.

Chronic lung disease linked to cognitive impairment, memory loss

December 12, 2013
A recent Mayo Clinic study found that people with chronic obstructive pulmonary disease (COPD) are about twice as likely to develop mild cognitive impairment (MCI)—and chances are that it will include memory loss. The study ...

Antioxidants speed lung cancer growth in mice, study finds

January 29, 2014
People who smoke or have lung cancer should think twice about taking vitamin supplements, according to a Swedish study Wednesday that showed certain antioxidants may make tumors grow faster.

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.